Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
"What we are seeing is that by improving metabolic health with these medications, we're decreasing a whole host of diseases 16 types of cancer, cardiovascular disease, dementia, Alzheimer's." But while the potential benefits of GLP-1s seem promising, there are other less desirable effects of the powerful medications
The Canadian Peptide Research Society is one organization helping advance peptide science in Canada through: research collaboration education and training scientific conferences and knowledge sharing exploration of emerging clinical applications You can learn more about their work here: Current research efforts in Canada and internationally are focused on: developing peptide-based medications (e.g., metabolic and hormone therapies) understanding how peptides influence tissue repair and inflammation advancing drug discovery and personalized medicine However, in musculoskeletal medicine specifically: most research remains preclinical (animal and laboratory studies) high-quality human clinical trials are still limited What this means for patients: Peptide research is an active and evolving field, and Canada is contributing to its development
Akkermansia is not a replacement for GLP-1 medications, but it may help support the gut conditions tied to natural metabolic signaling, including mucosal integrity, SCFA production, inflammatory balance, and microbiome resilience
Your pharmacy should provide a dose chart specific to your vial concentration
These employers can work directly with their pharmacy benefit manager (PBM) to negotiate terms, adjust plan design, and create strategies specific to their population
Based on our data, and on the calls to my clinic in the last few weeks, I think there is going to be robust demand under the Bridge program, said Oshman
